Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in MS Patients.

Alping P, Askling J, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T.

Ann Neurol. 2020 Feb 13. doi: 10.1002/ana.25701. [Epub ahead of print]

PMID:
32056253
2.

Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry.

Carlsson H, Abujrais S, Herman S, Khoonsari PE, Åkerfeldt T, Svenningsson A, Burman J, Kultima K.

Metabolomics. 2020 Feb 12;16(2):26. doi: 10.1007/s11306-020-1648-5.

PMID:
32052189
3.

Serum sickness following rituximab therapy in multiple sclerosis.

Holmøy T, Fogdell-Hahn A, Svenningsson A.

Neurol Clin Pract. 2019 Dec;9(6):519-521. doi: 10.1212/CPJ.0000000000000685. No abstract available.

PMID:
32042497
4.

Prevention of post-dural puncture headache - a randomized controlled trial.

Salzer J, Granåsen G, Sundström P, Vågberg M, Svenningsson A.

Eur J Neurol. 2020 Jan 29. doi: 10.1111/ene.14158. [Epub ahead of print]

PMID:
31997481
5.

Nonoperative Treatment Versus Appendectomy for Acute Nonperforated Appendicitis in Children: Five-year Follow Up of a Randomized Controlled Pilot Trial.

Patkova B, Svenningsson A, Almström M, Eaton S, Wester T, Svensson JF.

Ann Surg. 2019 Nov 21. doi: 10.1097/SLA.0000000000003646. [Epub ahead of print]

PMID:
31800496
6.

Reply to Sun et al.

Ericson H, Hamdeh SA, Freyhult E, Stiger F, Bäckryd E, Svenningsson A, Gordh T, Kultima K.

Pain. 2019 Dec;160(12):2898-2899. doi: 10.1097/j.pain.0000000000001699. No abstract available.

PMID:
31725083
7.

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T.

JAMA Neurol. 2019 Oct 7. doi: 10.1001/jamaneurol.2019.3365. [Epub ahead of print]

PMID:
31589278
8.

Erratum to 'Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters' (Br J Anaesth 2019; 123: 316-24).

Östlund Å, Fläring U, Norberg Å, Dahlberg A, Berner J, Kaiser S, Vermin L, Svenningsson A, Frisk T, Larsson P, Andersson A.

Br J Anaesth. 2019 Dec;123(6):918. doi: 10.1016/j.bja.2019.09.001. Epub 2019 Sep 20. No abstract available.

PMID:
31547971
9.

[Diagnostic challenge in a man with intractable hiccups and vomiting: a case of neuromyelitis optica spectrum disorder (NMOSD)].

Kaloudi D, Svenningsson A, von Heijne A.

Lakartidningen. 2019 Aug 13;116. pii: FL4F. Swedish.

10.

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.

Granqvist M, Burman J, Gunnarsson M, Lycke J, Nilsson P, Olsson T, Sundström P, Svenningsson A, Vrethem M, Frisell T, Piehl F.

Mult Scler. 2019 Aug 8:1352458519866600. doi: 10.1177/1352458519866600. [Epub ahead of print]

PMID:
31392923
11.

Cerebrospinal fluid biomarkers of inflammation in trigeminal neuralgia patients operated with microvascular decompression.

Ericson H, Abu Hamdeh S, Freyhult E, Stiger F, Bäckryd E, Svenningsson A, Gordh T, Kultima K.

Pain. 2019 Nov;160(11):2603-2611. doi: 10.1097/j.pain.0000000000001649.

PMID:
31373951
12.

β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly.

Svenningsson AL, Stomrud E, Insel PS, Mattsson N, Palmqvist S, Hansson O.

Sci Rep. 2019 Aug 1;9(1):11180. doi: 10.1038/s41598-019-47638-y.

13.

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ.

JAMA Neurol. 2019 Jun 17. doi: 10.1001/jamaneurol.2019.1534. [Epub ahead of print]

PMID:
31206160
14.

Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters.

Östlund Å, Fläring U, Norberg Å, Dahlberg A, Berner J, Kaiser S, Vermin L, Svenningsson A, Frisk T, Larsson P, Andersson A.

Br J Anaesth. 2019 Sep;123(3):316-324. doi: 10.1016/j.bja.2019.04.055. Epub 2019 Jun 6. Erratum in: Br J Anaesth. 2019 Dec;123(6):918.

PMID:
31176448
15.

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.

Söderholm J, Yilmaz A, Svenningsson A, Büsch K, Wejstål R, Brolund A, Kövamees J, Sällberg M, Lagging M, Gisslén M.

J Neurol. 2019 Sep;266(9):2208-2215. doi: 10.1007/s00415-019-09397-8. Epub 2019 May 31.

16.

Population-based cohort study of the correlation between provision of care and the risk for complications after appendectomy in children.

Almström M, Svensson JF, Svenningsson A, Hagel E, Wester T.

J Pediatr Surg. 2019 Nov;54(11):2279-2284. doi: 10.1016/j.jpedsurg.2019.03.013. Epub 2019 Mar 28.

17.

Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease.

Feresiadou A, Nilsson K, Ingelsson M, Press R, Kmezic I, Nygren I, Svenningsson A, Niemelä V, Gordh T, Cunningham J, Kultima K, Larsson A, Burman J.

J Neuroimmunol. 2019 Jul 15;332:31-36. doi: 10.1016/j.jneuroim.2019.03.015. Epub 2019 Mar 25.

PMID:
30928869
18.

Inflammatory activity and vitamin D levels in an MS population treated with rituximab.

Linden J, Granåsen G, Salzer J, Svenningsson A, Sundström P.

Mult Scler J Exp Transl Clin. 2019 Feb 11;5(1):2055217319826598. doi: 10.1177/2055217319826598. eCollection 2019 Jan-Mar.

19.

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis.

Boremalm M, Juto A, Axelsson M, Novakova L, Frisell T, Svenningsson A, Lycke J, Piehl F, Salzer J.

Eur J Neurol. 2019 Aug;26(8):1060-1067. doi: 10.1111/ene.13936. Epub 2019 Mar 12.

PMID:
30762259
20.

Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.

de Flon P, Laurell K, Sundström P, Blennow K, Söderström L, Zetterberg H, Gunnarsson M, Svenningsson A.

Acta Neurol Scand. 2019 May;139(5):462-468. doi: 10.1111/ane.13078. Epub 2019 Mar 5.

PMID:
30740668
21.

Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome.

Zetterberg H, Svenningsson A.

Neurology. 2019 Feb 12;92(7):313-314. doi: 10.1212/WNL.0000000000006906. Epub 2019 Jan 11. No abstract available.

PMID:
30635493
22.

Intrathecal treatment trial of rituximab in progressive MS: An open-label phase 1b study.

Bergman J, Burman J, Gilthorpe JD, Zetterberg H, Jiltsova E, Bergenheim T, Svenningsson A.

Neurology. 2018 Nov 13;91(20):e1893-e1901. doi: 10.1212/WNL.0000000000006500. Epub 2018 Oct 10.

PMID:
30305449
23.

Population-based cohort study on the epidemiology of acute appendicitis in children in Sweden in 1987-2013.

Almström M, Svensson JF, Svenningsson A, Hagel E, Wester T.

BJS Open. 2018 Apr 19;2(3):142-150. doi: 10.1002/bjs5.52. eCollection 2018 Jun.

24.

Maternal risk factors and perinatal characteristics of anorectal malformations.

Svenningsson A, Gunnarsdottir A, Wester T.

J Pediatr Surg. 2018 Nov;53(11):2183-2188. doi: 10.1016/j.jpedsurg.2018.04.021. Epub 2018 Apr 17.

PMID:
29907315
25.

Early central line-associated blood stream infections in children with cancer pose a risk for premature catheter removal.

Moell J, Svenningsson A, Af Sandeberg M, Larsson M, Heyman M, Harila-Saari A, Nilsson A.

Acta Paediatr. 2019 Feb;108(2):361-366. doi: 10.1111/apa.14432. Epub 2018 Jun 27.

PMID:
29863780
26.

Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls.

de Flon P, Söderström L, Laurell K, Dring A, Sundström P, Gunnarsson M, Svenningsson A.

PLoS One. 2018 Feb 8;13(2):e0192516. doi: 10.1371/journal.pone.0192516. eCollection 2018.

27.

Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis.

Granqvist M, Boremalm M, Poorghobad A, Svenningsson A, Salzer J, Frisell T, Piehl F.

JAMA Neurol. 2018 Mar 1;75(3):320-327. doi: 10.1001/jamaneurol.2017.4011.

28.

Cortico-juxtacortical and periventricular lesions and MS diagnostic criteria.

Svenningsson A, Ciccarelli O.

Neurology. 2017 Dec 5;89(23):2308-2309. doi: 10.1212/WNL.0000000000004725. Epub 2017 Nov 3. No abstract available.

PMID:
29101273
29.

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.

Novakova L, Zetterberg H, Sundström P, Axelsson M, Khademi M, Gunnarsson M, Malmeström C, Svenningsson A, Olsson T, Piehl F, Blennow K, Lycke J.

Neurology. 2017 Nov 28;89(22):2230-2237. doi: 10.1212/WNL.0000000000004683. Epub 2017 Oct 27.

30.

In-hospital Surgical Delay Does Not Increase the Risk for Perforated Appendicitis in Children: A Single-center Retrospective Cohort Study.

Almström M, Svensson JF, Patkova B, Svenningsson A, Wester T.

Ann Surg. 2017 Mar;265(3):616-621. doi: 10.1097/SLA.0000000000001694.

PMID:
28169930
31.

Brain Parenchymal Fraction in Healthy Adults-A Systematic Review of the Literature.

Vågberg M, Granåsen G, Svenningsson A.

PLoS One. 2017 Jan 17;12(1):e0170018. doi: 10.1371/journal.pone.0170018. eCollection 2017. Review.

32.

How to minimize the risk for headache? A lumbar puncture practice questionnaire study.

Salzer J, Rajda C, Sundström P, Vågberg M, Vécsei L, Svenningsson A.

Ideggyogy Sz. 2016 Nov 30;69(11-12):397-402. doi: 10.18071/isz.69.0397.

PMID:
29733557
33.

Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS.

de Flon P, Laurell K, Söderström L, Gunnarsson M, Svenningsson A.

Mult Scler. 2017 Aug;23(9):1249-1257. doi: 10.1177/1352458516676643. Epub 2016 Oct 25.

PMID:
27780912
34.

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.

Salzer J, Svenningsson R, Alping P, Novakova L, Björck A, Fink K, Islam-Jakobsson P, Malmeström C, Axelsson M, Vågberg M, Sundström P, Lycke J, Piehl F, Svenningsson A.

Neurology. 2016 Nov 15;87(20):2074-2081. Epub 2016 Oct 19.

35.

Brain parenchymal fraction in an age-stratified healthy population - determined by MRI using manual segmentation and three automated segmentation methods.

Vågberg M, Ambarki K, Lindqvist T, Birgander R, Svenningsson A.

J Neuroradiol. 2016 Dec;43(6):384-391. doi: 10.1016/j.neurad.2016.08.002. Epub 2016 Oct 5.

PMID:
27720265
36.

Population-based study shows that Hirschsprung disease does not have a negative impact on education and income.

Granström AL, Svenningsson A, Nordenskjöld A, Wester T.

Acta Paediatr. 2016 Dec;105(12):1508-1512. doi: 10.1111/apa.13594. Epub 2016 Oct 9.

PMID:
27639057
37.

Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society.

Vågberg M, Axelsson M, Birgander R, Burman J, Cananau C, Forslin Y, Granberg T, Gunnarsson M, von Heijne A, Jönsson L, Karrenbauer VD, Larsson EM, Lindqvist T, Lycke J, Lönn L, Mentesidou E, Müller S, Nilsson P, Piehl F, Svenningsson A, Vrethem M, Wikström J.

Acta Neurol Scand. 2017 Jan;135(1):17-24. doi: 10.1111/ane.12667. Epub 2016 Aug 24. Review.

38.

Reply.

Alping P, Frisell T, Svenningsson A, Piehl F.

Ann Neurol. 2016 Nov;80(5):791-792. doi: 10.1002/ana.24767. Epub 2016 Sep 27. No abstract available.

PMID:
27553863
39.

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.

Bergman J, Dring A, Zetterberg H, Blennow K, Norgren N, Gilthorpe J, Bergenheim T, Svenningsson A.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 2;3(5):e271. doi: 10.1212/NXI.0000000000000271. eCollection 2016 Oct.

40.

Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab.

de Flon P, Gunnarsson M, Laurell K, Söderström L, Birgander R, Lindqvist T, Krauss W, Dring A, Bergman J, Sundström P, Svenningsson A.

Neurology. 2016 Jul 12;87(2):141-7. doi: 10.1212/WNL.0000000000002832. Epub 2016 Jun 17.

PMID:
27316241
41.

Maternal Risk Factors and Perinatal Characteristics for Hirschsprung Disease.

Löf Granström A, Svenningsson A, Hagel E, Oddsberg J, Nordenskjöld A, Wester T.

Pediatrics. 2016 Jul;138(1). pii: e20154608. doi: 10.1542/peds.2015-4608. Epub 2016 Jun 15.

42.

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.

Alping P, Frisell T, Novakova L, Islam-Jakobsson P, Salzer J, Björck A, Axelsson M, Malmeström C, Fink K, Lycke J, Svenningsson A, Piehl F.

Ann Neurol. 2016 Jun;79(6):950-8. doi: 10.1002/ana.24651. Epub 2016 Apr 20.

PMID:
27038238
43.

Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

Burman J, Svenningsson A.

J Neuroimmunol. 2016 Mar 15;292:40-4. doi: 10.1016/j.jneuroim.2016.01.008. Epub 2016 Jan 16.

PMID:
26943957
44.

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.

Al Nimer F, Elliott C, Bergman J, Khademi M, Dring AM, Aeinehband S, Bergenheim T, Romme Christensen J, Sellebjerg F, Svenningsson A, Linington C, Olsson T, Piehl F.

Neurol Neuroimmunol Neuroinflamm. 2016 Jan 7;3(1):e191. doi: 10.1212/NXI.0000000000000191. eCollection 2016 Feb.

45.

Rituximab in paediatric onset multiple sclerosis: a case series.

Salzer J, Lycke J, Wickström R, Naver H, Piehl F, Svenningsson A.

J Neurol. 2016 Feb;263(2):322-326. doi: 10.1007/s00415-015-7979-x. Epub 2015 Nov 24.

PMID:
26603152
46.

Vitamin D and axonal injury in multiple sclerosis.

Sandberg L, Biström M, Salzer J, Vågberg M, Svenningsson A, Sundström P.

Mult Scler. 2016 Jul;22(8):1027-31. doi: 10.1177/1352458515606986. Epub 2015 Oct 13.

PMID:
26462862
47.

Outcomes in infants with prenatally diagnosed gastroschisis and planned preterm delivery.

Mesas Burgos C, Svenningsson A, Vejde JH, Granholm T, Conner P.

Pediatr Surg Int. 2015 Nov;31(11):1047-53. doi: 10.1007/s00383-015-3795-8. Epub 2015 Sep 23.

PMID:
26399421
48.

Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden.

Wickström A, Sundström P, Wickström L, Dahle C, Vrethem M, Svenningsson A.

Mult Scler J Exp Transl Clin. 2015 Sep 22;1:2055217315608203. doi: 10.1177/2055217315608203. eCollection 2015 Jan-Dec.

49.

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.

Vågberg M, Norgren N, Dring A, Lindqvist T, Birgander R, Zetterberg H, Svenningsson A.

PLoS One. 2015 Aug 28;10(8):e0135886. doi: 10.1371/journal.pone.0135886. eCollection 2015.

50.

Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.

Al Nimer F, Thelin E, Nyström H, Dring AM, Svenningsson A, Piehl F, Nelson DW, Bellander BM.

PLoS One. 2015 Jul 2;10(7):e0132177. doi: 10.1371/journal.pone.0132177. eCollection 2015.

Supplemental Content

Loading ...
Support Center